Shield Therapeutics (STX.L) Stock Price
£3.55 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Shield Therapeutics, AI stock picks, stock alerts and much more.
STX.L AI Stock Analysis
AI stock analysis for STX.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Shield Therapeutics (STX.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Shield Therapeutics (STX.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Shield Therapeutics (STX.L), currently trading at £3.55, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About STX.L
-
Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs.
-
Symbol
STX.L
-
Market
LSE
-
Industry
Drug Manufacturers - Specialty & Generic
-
Market Cap
37M
Similar Stocks
 |
Indivior PLC INDV.L |
£1198 1.9% |
5 |
 |
Haleon plc HLN.L |
£358.7 0% |
7 |
 |
HUTCHMED (China) Limited HCM.L |
£258 2.4% |
5 |
 |
Hikma Pharmaceuticals PLC HIK.L |
£2010 0.8% |
6 |
 |
Celadon Pharmaceuticals Plc CEL.L |
£13.4 16.5% |
5 |
News
STX.L Alternative Data
Web Traffic
Shield Therapeutics receives an estimated 1749 monthly visitors to shieldtherapeutics.com.
-
Web Traffic
1749
-
Change from Previous Month
6.6%
-
3 Month Change
25.7%
-
YoY Change
25.7%
Job Postings
Shield Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Shield Therapeutics has 623 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.6% over the last month.
-
Twitter Followers
623
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
0.2%
LinkedIn Employees
According to LinkedIn, Shield Therapeutics has 69 employees.
-
LinkedIn Employees
69
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.8%
Business Outlook
According to employee reviews, the business outlook among employees at Shield Therapeutics is 42 out of 100 (neutral).
-
Business Outlook
42
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Shield Therapeutics was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Shield Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
STX.L Financials
STX.L Key Metrics
-
Total Revenue
£15.5M
-
Net Income
-£9.1M
-
Earnings per Share
-£0.0087
-
Free cash flow
-£3.7M
-
EBITDA
-£6.1M
-
EBITDA Ratio
-0.395451
-
Total Assets
£45.9M
STX.L 2-year Revenue & Income
STX.L 2-year Free Cash Flow
STX.L Technicals
STX.L SMA
STX.L RSI
FAQ
What's the current price of Shield Therapeutics (STX.L) Stock?
The price of an Shield Therapeutics (STX.L) share is £3.55.
What's the market cap of Shield Therapeutics?
The current market cap of Shield Therapeutics is 37M.
Should I buy or sell STX.L?
Shield Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Shield Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Shield Therapeutics a good investment?
The current analysis of Shield Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Shield Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Shield Therapeutics (STX.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Shield Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Shield Therapeutics (STX.L) that investors often compare it to?
Shield Therapeutics (STX.L) is often compared to similar stocks such as Indivior PLC, Haleon plc, HUTCHMED (China) Limited, Hikma Pharmaceuticals PLC and Celadon Pharmaceuticals Plc.
What is the forecast for Shield Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Shield Therapeutics' stock price to be around £3.51 in 2026. Starting from the current price of £3.55, this represents a 1.2% change in price, indicating a neutral outlook for the stock.
How to buy Shield Therapeutics (STX.L) Stock?
Shield Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Shield Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.